Phase 1b News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MARSEILLE, France, October 05, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the lacutamab IND leading to a pause in new patient enrollment to the Company’s ongoing lacutamab trials IPH4102-201 (Phase 2 TELLOMAK) and 102 (Phase 1b PTCL). The partial clinical hold follows one fatal case of hemophagocytic lymphohistiocytosis (HLH), a rare

Robust decreases in serum IgM at low- and mid-doses suggest best-in-class potential for mavorixafor plus ibrutinib therapy in double-mutation Waldenström’s patients; meaningful increases in hemoglobin levels suggest reduction in cancer burden in bone marrow At 6 months, patients achieved median IgM level reductions of 60%-75%, with one patient achieving normal IgM, and two of four patients (50%) had >50% reduction in IgM from baseline e-Poster now available online; pre-recorded presentation by l

Chicago’s top doctor addressed recent news saying data so far has not shown any “safety signals” for pregnant women and their unborn babies.

New guidance from the Centers for Disease Control and Prevention indicates a recent study found "no obvious safety signals" surrounding vaccination in pregnant women. The researchers looked at data from 35,691 women, who ranged in age from 16 to 54, in a peer-reviewed study published this week in The New England Journal of Medicine. Data used in the research was self-reported using the "v-safe after vaccination health checker," researchers noted. "No safety concerns were observed for people vaccinated in the third trimester or safety concerns for their babies," CDC Director Dr. Rochelle Wale...

Disability sector labels wait for COVID-19 vaccines 'shameful' updated 4 The disability sector is frustrated at the lack of transparency over vaccine data. ( Print text only Cancel As Australia enters its eighth week of the COVID-19 vaccine rollout, thousands of the nation's most vulnerable are still waiting for their first dose. Key points: One of Australia's largest disability service providers says they are yet to receive a single dose of coronavirus vaccines Residents and workers in specialist disability accommodation were placed in Phase 1A of the rollout At the end of March, vaccinati...